Similarly, the ileocolonic delivery of mixed bile acids (1 g/day) increases GLP-1 secretion and reduces postprandial blood glucose levels in patients with obesity and T2DM during a 4-week treatment [210]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.